T J McElwain
Overview
Explore the profile of T J McElwain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
1416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Millar B, Maitland J, Bell J, McElwain T
Leuk Lymphoma
. 2016 Jul;
2(5):271-7.
PMID: 27456916
Myeloma is a disease of the B cell lineage which is characterized by the presence of excess numbers of isotypic plasma cells in the bone marrow and a serum paraprotein...
2.
Patel P, Selby P, Graham M, Viner C, Newell D, McElwain T
Hematol Oncol
. 1993 Mar;
11(2):89-96.
PMID: 8406379
The pharmacokinetics of oral and intravenous high dose methylprednisolone (Solu-medrone, Upjohn) were compared in patients with hematological malignancies. The aim of the study was to determine the oral bioavailability of...
3.
James N, Kingston J, Plowman P, Meller S, Pinkerton R, Barrett A, et al.
Br J Cancer
. 1992 Dec;
66(6):1155-8.
PMID: 1457357
During the period 1974-89, 169 children with Hodgkin's disease were treated in the Paediatric Oncology Units of the Royal Marsden and St Bartholomew's Hospitals. The overall actuarial survival for the...
4.
OBrien M, Pinkerton C, Kingston J, Mott M, Tait D, Meller S, et al.
Br J Cancer
. 1992 May;
65(5):756-60.
PMID: 1586603
In an attempt to decrease the risk of second malignancies and future infertility in children with Hodgkin's disease (HD) while retaining acceptable remission rates, an anthracycline based regimen containing no...
5.
Millar B, Bell J, Millar J, Treleaven J, Montes A, Joffe J, et al.
Exp Hematol
. 1992 Feb;
20(2):209-15.
PMID: 1371966
Colony-stimulating activity (CSA) in the serum of patients with hematological malignancies increased substantially after intensive therapy with cyclophosphamide/busulfan, cyclophosphamide/total body irradiation, or melphalan/total body irradiation. This was not dependent on...
6.
Ryalls M, Pinkerton C, Meller S, Talbot D, McElwain T
Med Pediatr Oncol
. 1992 Jan;
20(2):119-23.
PMID: 1734216
Twenty children received methylprednisolone (1 g/m2), daily for 5 to 8 days, as initial single agent therapy for relapsed acute lymphoblastic leukaemia. Bone marrow blasts were reduced to less than...
7.
Pinkerton C, Barrett A, Meller S, Tait D, Ashley S, McElwain T
Br J Cancer
. 1991 Aug;
64(2):381-5.
PMID: 1892770
Forty-three children with malignant soft tissue sarcomas (IRS Groups II-IV) were treated with rapid dose delivery chemotherapy protocol comprising six courses of vincristine, adriamycin and cyclophosphamide, given in most cases...
8.
OConnell M, Hoskin P, Mayles W, McElwain T, Barrett A
Clin Oncol (R Coll Radiol)
. 1991 Jul;
3(4):236-9.
PMID: 1931767
Three patients with vaginal rhabdomyosarcoma and residual vaginal disease following surgery and chemotherapy have been treated using high dose irradiation with vaginal moulds loaded with iridium-192. These patients remain well...
9.
Schroeder H, Pinkerton C, Powles R, Meller S, Tait D, Milan S, et al.
Bone Marrow Transplant
. 1991 Jan;
7(1):11-5.
PMID: 2043872
High dose melphalan (HDM 110-140 mg/m2) and total body irradiation (TBI, 10.5 Gy, single fraction) followed by infusion of autologous bone marrow (ABMT) was evaluated for toxicity and efficacy in...
10.
Borinaga A, Millar B, Bell J, Joffe J, Millar J, Gooding R, et al.
Br J Haematol
. 1990 Dec;
76(4):476-83.
PMID: 2265109
Several groups have claimed that IL-6 is a growth factor for human myeloma cells in vitro. Bone marrow aspirates from 30 patients at different stages of treatment with VAMP/high dose...